Feb 17, 2012

Kalbe Farma eyes 20% growth in sales

Pharmaceutical company PT Kalbe Farma Tbk (KLBF) is scouting a 15%-20% increase in sales this year to Rp12.54 trillion-Rp13.08 trillion from Rp10.90 trillion last year.
Finance Director Vidjongtius at Kalbe Farma said the company booked a 6.7% increase in sales last year from Rp10.22 trillion.
Net profit last year rose 13.8% to Rp1.46 trillion from Rp1.28 trillion, while net profit per share increased 13.8% to Rp156 from Rp137.

Disclosure: No position at the stock mentioned above.

Print This Article

No comments: